I kliniske akut tibiafraktur studier oplevede flere InductOs patienter, som samtidig tog NSAID i 14 sammenhængende dage, milde eller moderate bivirkninger i forbindelse med sårheling (f. eks. sårdræn) end InductOs patienter, der ikke tog NSAID.
In acute tibia fracture clinical trials, more InductOs patients receiving concomitant NSAIDs for 14 consecutive days experienced mild or moderate adverse events related to wound healing (e.g. wound drainage) than InductOs patients not taking NSAIDs.